Likelihood to be helped or harmed can assist in clinical decision-making.
作者信息
Citrome Leslie
出版信息
J Clin Psychiatry. 2011 Feb;72(2):261-2; author reply 262. doi: 10.4088/JCP.10lr06663gre.
PMID:21382311
Abstract
摘要
相似文献
1
Likelihood to be helped or harmed can assist in clinical decision-making.
J Clin Psychiatry. 2011 Feb;72(2):261-2; author reply 262. doi: 10.4088/JCP.10lr06663gre.
2
Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation.
CNS Spectr. 2007 Dec;12(12 Suppl 22):13-5.
3
[Effect of neuroleptics on depressive symptoms].
Encephale. 1998 Jul;24 Spec No 1:38-41.
4
Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
J Clin Psychopharmacol. 2009 Feb;29(1):91-2; author reply 92-3. doi: 10.1097/JCP.0b013e318194087c.
5
Aripiprazole in refractory depression?
J Clin Psychopharmacol. 2009 Feb;29(1):90-1; author reply 92-3. doi: 10.1097/JCP.0b013e318193c9b1.
6
High CSF Tau-protein concentration in delirium induced by high dose psychiatric medication.
Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):1039-41. doi: 10.1111/j.1440-1614.2006.01933.x.
7
Efficacy of blonanserin in combination therapy for treatment-resistant depression.
Psychiatry Clin Neurosci. 2009 Aug;63(4):593-4. doi: 10.1111/j.1440-1819.2009.01966.x.
8
Atypical antipsychotic augmentation in treatment-resistant major depressive disorder.
Conn Med. 2011 Mar;75(3):153-6.
9
[Severe depression : specific features of bipolar disorder].
Encephale. 2009 Dec;35 Suppl 7:S261-3. doi: 10.1016/S0013-7006(09)73482-7.
10
The modern pharmacopoeia: a return to depressive realism?
Bipolar Disord. 2008 Dec;10(8):969-72. doi: 10.1111/j.1399-5618.2008.00632.x.
Zotero 插件